Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

‘Gas station heroin’: the drug sold as a dietary supplement that’s linked to overdoses and deaths

The US Food and Drug Administration (FDA) has issued an urgent warning about tianeptine – a substance marketed as a dietary supplement but known on the street as “gas station heroin”.

The Conversation

9 Common Reasons Why Everyday Snacks Face National Recalls

Snack foods are a pantry staple in most homes. We trust that the chips, crackers, cookies, and bars we buy are safe to eat. However, snack products are frequently the subject of national food recalls. These recalls occur when a product is found to pose a potential health risk to…

Grocery Coupon Guide

10 of the Worst State Laws Going Into Effect in July

From minimum wage hikes to bans on cellphones in public schools, here are some of the most ridiculous ways state governments are interfering with Americans’ lives.

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

Parental Rights and Youth Gender Medicine

The Supreme Court just declined this morning to consider this issue, but here's how a noted lower court judge analyzed the matter.

Reason

‘People who badly need’: RFK Jr. doesn’t believe in vaccines but thinks drugs are the answer

Where does he get his facts?

We Got This Covered

Travere Therapeutics Draws Institutional Interest from Armistice Capital, Driehaus, and Wellington

Armistice Capital holds 8.9M shares in Travere Therapeutics as rare kidney disease stock climbs 110% following FILSPARI's full FDA approval.

International Business Times

3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?

Nektar Therapeutics soared 157% after Rezpeg succeeded in a Phase 2b eczema trial. Analysts forecast huge upside—here’s why there could be more gains ahead.

MarketBeat

A rundown of recent Trump administration vaccine policy changes

The Trump administration is continuing to make its imprint on U.S. vaccine policy in recent days

The Independent UK

RFK Jr.'s made promises about vaccines. Here's what he's done as health secretary

The Department of Health and Human Services under Robert F

The Independent UK

COVID Vaccine Side Effects: FDA Announces Rare Heart-Related Reactions - What You Should Know

FDA has updated safety warnings for the Pfizer-BioNTech (Comirnaty) and Moderna (Spikevax) COVID-19 vaccines.

International Business Times UK

Panel recommends removing thimerosal from flu vaccines - Roll Call

A key vaccine policy advisory group is recommending the public not receive vaccines that have thimerosal, a mercury-containing preservative.

Roll Call

7 Medical Devices Banned for Mental Health Treatment in Certain Countries

The history of mental health treatment is a complex and often unsettling journey. As our understanding of the human mind evolves, so do our standards for providing ethical and effective care. Many treatments that were once mainstream have since been abandoned by doctors. These older methods were often brutal, lacked…

Budget and the Bees

Steve Cohen's Point72 Goes Heavy on Tech and Pharma Stocks, Investing Over $330M in Two Trades

Point72 Asset Management recently purchased over 10 million shares of Confluent and Amylyx Pharma common stock, worth more than $334.17 million.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

The psychedelic front line: how magic mushrooms and MDMA could cure ravaged soldiers’ PTSD

The hot topic at Psychedelic Science Conference 2025 was the potential for treating PTSD with MDMA and magic mushrooms

The Independent UK

FDA requires updated warning about rare heart risk with COVID shots

U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines

Benzinga

HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?

Telehealth darling Hims Hers Health Inc (NYSE:HIMS) got slapped with a 34% stock crash on Monday. Novo Nordisk A/S (NYSE:NVO) ended their relationship – and it wasn't amicable.

The Independent UK

Texas will put warning labels on some foods, but its additives list has inaccuracies

A Texas law promoting the Trump administration’s “Make America Healthy Again” agenda requires first-ever warning labels on certain foods like chips and candies

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

US approves twice-yearly injection for HIV prevention – what you need to know about lenacapavir

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new treatment marks a major advancement in expanding prevention options for people at risk of HIV infection.

International Business Times UK

Why Did Novo Nordisk Pull the Plug on Hims Collaboration?

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, unapproved Wegovy knock-offs. Hims' stock tanked, and legal risks loom.

Saving Advice

6 Food Additives That Are Legal Here But Illegal Everywhere Else

In the United States, it’s easy to assume that if something’s on grocery store shelves, it must be safe. But take a closer look at...

International Business Times UK

Hims Stock Tumbles Down After Abrupt Exit of Novo Nordisk: Here's Everything That Went Wrong

Novo Nordisk alleged that some telehealth entities, including Hims & Hers, used illicit semaglutide sourced from unregulated Chinese manufacturers not approved or inspected by the FDA.

Benzinga

Hims & Hers Health Stock Is Tumbling Monday: What's Happening?

Hims Hers Health Inc (NYSE:HIMS) shares are trading lower Monday after Novo Nordisk A/S (NYSE:NVO) terminated its collaboration with the company.

The Guardian - US

As a heatwave approaches, experts say US sunscreens are less effective than those abroad

Other countries have approved a wider range of UV-filtering ingredients, which allow for more advanced sunscreens

Barchart

Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?

These two names could be long-term biotech plays for those willing to take the high-risk road.

1 … 41 42 43 44

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.